Creative Compounds

FDA Regulatory Profile

Creative Compounds appears in FDA public data with 2 recalls, 0 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (H-0900-2026, Class II) was initiated on December 15, 2025.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
5
Compliance Actions
0

Recent Recalls

NumberClassProductDate
H-0900-2026Class IIBetaine Anhydrous, 2055kg, material packed in foil bags inside 15kg cardboard box Label reads in parDecember 15, 2025
D-1019-2013Class IIGlutathione 100 mg/mL Injectable, 100mL Vial, Use as Directed, RX, Creative Compounds, Wilsonville, August 23, 2013